Cierra N. Sharp

Cierra N. Sharp

Jun 01, 2016

Group 6 Copy 58
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    The Mystery of the Disappearing Seabirds: Using Science to Protect Caribbean Seabirds

    Seabirds are among the most endangered of all vertebrate groups. Loss of Caribbean populations is ongoing; many...

    Join the Journey: Golden-winged Warbler Migration

    Donate to our U Maine gift account. Golden-winged Warbler is one of North America's fastest declining forest...

    Do differences in coral skeletal architecture influence bleaching susceptibility?

    Reef-building corals are bleaching and dying at unprecedented rates due to ocean warming. However, corals bleach...

    Backer Badge Funded